623 related articles for article (PubMed ID: 17289299)
1. Impact of a reduction in heroin availability on patterns of drug use, risk behaviour and incidence of hepatitis C virus infection in injecting drug users in New South Wales, Australia.
Maher L; Li J; Jalaludin B; Wand H; Jayasuriya R; Dixon D; Kaldor JM
Drug Alcohol Depend; 2007 Jul; 89(2-3):244-50. PubMed ID: 17289299
[TBL] [Abstract][Full Text] [Related]
2. The impact of changes to heroin supply on blood-borne virus notifications and injecting related harms in New South Wales, Australia.
Day C; Degenhardt L; Gilmour S; Hall W
BMC Public Health; 2005 Aug; 5():84. PubMed ID: 16102177
[TBL] [Abstract][Full Text] [Related]
3. Patterns of drug use and associated harms among rural injecting drug users: comparisons with metropolitan injecting drug users.
Day C; Conroy E; Lowe J; Page J; Dolan K
Aust J Rural Health; 2006 Jun; 14(3):120-5. PubMed ID: 16706881
[TBL] [Abstract][Full Text] [Related]
4. Changes in patterns of drug use among injecting drug users following changes in the availability of heroin in New South Wales, Australia.
Roxburgh A; Degenhardt L; Breen C
Drug Alcohol Rev; 2004 Sep; 23(3):287-94. PubMed ID: 15370008
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of injecting drug use and associated risk behavior among regular ecstasy users in Australia.
White B; Day C; Degenhardt L; Kinner S; Fry C; Bruno R; Johnston J
Drug Alcohol Depend; 2006 Jul; 83(3):210-7. PubMed ID: 16343810
[TBL] [Abstract][Full Text] [Related]
6. Effects of a sustained heroin shortage in three Australian States.
Degenhardt L; Day C; Dietze P; Pointer S; Conroy E; Collins L; Hall W
Addiction; 2005 Jul; 100(7):908-20. PubMed ID: 15954999
[TBL] [Abstract][Full Text] [Related]
7. Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia.
Maher L; Jalaludin B; Chant KG; Jayasuriya R; Sladden T; Kaldor JM; Sargent PL
Addiction; 2006 Oct; 101(10):1499-508. PubMed ID: 16968352
[TBL] [Abstract][Full Text] [Related]
8. A longitudinal investigation into excess risk for blood-borne infection among young injection drug users (IUDs).
Miller CL; Strathdee SA; Li K; Kerr T; Wood E
Am J Drug Alcohol Abuse; 2007; 33(4):527-36. PubMed ID: 17668338
[TBL] [Abstract][Full Text] [Related]
9. Changes in the initiation of heroin use after a reduction in heroin supply.
Day C; Degenhardt L; Hall W
Drug Alcohol Rev; 2006 Jul; 25(4):307-13. PubMed ID: 16854655
[TBL] [Abstract][Full Text] [Related]
10. Injecting behaviours and prevalence of hepatitis B, C and D markers in New Zealand injecting drug user populations.
Kemp R; Miller J; Lungley S; Baker M
N Z Med J; 1998 Feb; 111(1060):50-3. PubMed ID: 9539916
[TBL] [Abstract][Full Text] [Related]
11. Impact of the heroin 'drought' on patterns of drug use and drug-related harms.
Longo MC; Henry-Edwards SM; Humeniuk RE; Christie P; Ali RL
Drug Alcohol Rev; 2004 Jun; 23(2):143-50. PubMed ID: 15370019
[TBL] [Abstract][Full Text] [Related]
12. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
Vicknasingam B; Narayanan S; Navaratnam V
Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801
[TBL] [Abstract][Full Text] [Related]
13. Estimating population attributable risk for hepatitis C seroconversion in injecting drug users in Australia: implications for prevention policy and planning.
Wand H; Spiegelman D; Law M; Jalaludin B; Kaldor J; Maher L
Addiction; 2009 Dec; 104(12):2049-56. PubMed ID: 19804463
[TBL] [Abstract][Full Text] [Related]
14. Contemporary cocaine use patterns and associated harms in Melbourne and Sydney, Australia.
Shearer J; Johnston J; Fry CL; Kaye S; Dillon P; Dietze P; Collins L
Drug Alcohol Rev; 2007 Sep; 26(5):537-43. PubMed ID: 17701517
[TBL] [Abstract][Full Text] [Related]
15. HCV seroconversion among never-injecting heroin users at baseline: no predictors identified other than starting injection.
Bravo MJ; Vallejo F; Barrio G; Brugal MT; Molist G; Pulido J; Sordo L; de la Fuente L;
Int J Drug Policy; 2012 Sep; 23(5):415-9. PubMed ID: 22421554
[TBL] [Abstract][Full Text] [Related]
16. Minimal uptake of sterile drug preparation equipment in a predominantly cocaine injecting population: implications for HIV and hepatitis C prevention.
Morissette C; Cox J; De P; Tremblay C; Roy E; Allard R; Stephenson R; Graves L
Int J Drug Policy; 2007 May; 18(3):204-12. PubMed ID: 17689367
[TBL] [Abstract][Full Text] [Related]
17. Buprenorphine injection in Melbourne, Australia--an update.
Aitken CK; Higgs PG; Hellard ME
Drug Alcohol Rev; 2008 Mar; 27(2):197-9. PubMed ID: 18264882
[TBL] [Abstract][Full Text] [Related]
18. [Risk factors for hepatitis C among injecting drug users in Oslo].
Dalgard O; Egeland A; Ervik R; Vilimas K; Skaug K; Steen TW
Tidsskr Nor Laegeforen; 2009 Jan; 129(2):101-4. PubMed ID: 19151801
[TBL] [Abstract][Full Text] [Related]
19. Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users.
Miller CL; Johnston C; Spittal PM; Li K; Laliberté N; Montaner JS; Schechter MT
Hepatology; 2002 Sep; 36(3):737-42. PubMed ID: 12198668
[TBL] [Abstract][Full Text] [Related]
20. The rising prevalence of prescription opioid injection and its association with hepatitis C incidence among street-drug users.
Bruneau J; Roy E; Arruda N; Zang G; Jutras-Aswad D
Addiction; 2012 Jul; 107(7):1318-27. PubMed ID: 22248184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
